FDA Okays Alternative to Botox, but Agency Warns of Risks for Both Drugs

The Food and Drug Administration has sanctioned a new wrinkle-remover, Dysport, for cosmetic and therapeutic use. Like Botox, it’s an injectable drug derived from a botulinum toxin. It has been sold in Europe at a price cheaper than Botox for several years, and it is expected to be available in this country in 60 days.

Read full story via washingtonpost

Short URL: http://www.plasticsurgeonsnews.com/?p=267

Posted by admin on Jun 2 2009. Filed under Injectables. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry